PARP Inhibitors for Prostate Cancer

Navigating Therapeutic Decision Making in Prostate CancerПодробнее

Upcoming Trials for mHSPC and mCRPC and Next-Generation SequencingПодробнее

Update on metastatic prostate cancer managementПодробнее

Prostate Cancer Perspectives: Clinical Insights and Emerging AdvancesПодробнее

Identifying Castration Resistance in Prostate CancerПодробнее

The Landscape of Radiopharmaceuticals and PARP Inhibitors in CRPCПодробнее

Watch Drs. Looney & Mazur discuss the latest #ProstateCancer updates: https://bit.ly/Prostate24-YПодробнее

Dr Elena Castro on PARPi in CR Prostate Cancer :Day2 #PROSCA24Подробнее

Candid Conversations in Prostate Cancer CareПодробнее

Prostate Cancer Guide for VA PharmacistsПодробнее

Emerging Radiopharmaceuticals and PARP Inhibitors in Prostate Cancer TreatmentПодробнее

PARP Inhibitors: Assessing the Clinical Trial LandscapeПодробнее

Watch Kassandra August-Marcucio & Grace Cullen discuss #ProstateCancer: bit.ly/VirginiaBeach24YПодробнее

An Overview of PARPi & Adverse Event ManagementПодробнее

Breakthrough Treatment Options for Prostate CancerПодробнее

New Therapies in Prostate Cancer: What do Urology Nurses and APPs Need to Know?Подробнее

Immuno-Oncology: A Focus on Prostate CancerПодробнее

Optimizing PARP Inhibitor Therapies in Veterans With Prostate CancerПодробнее

PARP Inhibitors: Assessing the Rapidly Evolving Treatment LandscapeПодробнее

PARP Inhibitors: Best Practices In Advanced Prostate Cancer Care In The CommunityПодробнее